Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony F Shields

Showing results (41-50 of 186) with videos related to

Pageof 19
Sort By:
Investigational New Drugs|July 8, 2010
Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort studyPatricia Lorusso, Anthony F Shields, Shirish Gadgeel, et al.
Pediatric Blood & Cancer|March 27, 2026
Poorly Differentiated Signet-Ring Cell Gastroesophageal Carcinoma in a Child With No Detectable Genetic Predisposition: Report of a Rare and Highly Aggressive TumorMohamad Bakkar, Madhvi Rajpurkar, Jeffrey W Taub, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Glucocorticoid receptor status is a principal determinant of variability in the sensitivity of non-small-cell lung cancer cells to pemetrexedMugdha Patki, Shirish Gadgeel, Yanfang Huang, et al.
American Journal of Clinical Oncology|February 11, 2003
Phase II study of paclitaxel and carboplatin in patients with advanced gastric cancerShirish M Gadgeel, Anthony F Shields, Lance K Heilbrun, et al.
Anticancer Research|March 19, 2017
Altered Levels of Serum Ceramide, Sphingosine and Sphingomyelin Are Associated with Colorectal Cancer: A Retrospective Pilot StudyDuska Separovic, Anthony F Shields, Philip A Philip, et al.
The Oncologist|July 13, 2016
Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET RegistryRathan M Subramaniam, Anthony F Shields, Archana Sachedina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 14, 2014
Impact of (18)F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Investigational New Drugs|November 6, 2004
Phase I study of liposomal doxorubicin (Doxil) and cyclophosphamide in solid tumorsBasil F El-Rayes, Dina Ibrahim, Anthony F Shields, et al.
Molecular Imaging and Biology|November 17, 2010
Impact of dedicated brain PET on intended patient management in participants of the national oncologic PET RegistryBruce E Hillner, Barry A Siegel, Anthony F Shields, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 9, 2004
Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancerHaihao Sun, Andrew Sloan, Thomas J Mangner, et al.
Pageof 19

Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Investigational New Drugs|July 8, 2010
Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort studyPatricia Lorusso, Anthony F Shields, Shirish Gadgeel, et al.
Pediatric Blood & Cancer|March 27, 2026
Poorly Differentiated Signet-Ring Cell Gastroesophageal Carcinoma in a Child With No Detectable Genetic Predisposition: Report of a Rare and Highly Aggressive TumorMohamad Bakkar, Madhvi Rajpurkar, Jeffrey W Taub, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Glucocorticoid receptor status is a principal determinant of variability in the sensitivity of non-small-cell lung cancer cells to pemetrexedMugdha Patki, Shirish Gadgeel, Yanfang Huang, et al.
American Journal of Clinical Oncology|February 11, 2003
Phase II study of paclitaxel and carboplatin in patients with advanced gastric cancerShirish M Gadgeel, Anthony F Shields, Lance K Heilbrun, et al.
Anticancer Research|March 19, 2017
Altered Levels of Serum Ceramide, Sphingosine and Sphingomyelin Are Associated with Colorectal Cancer: A Retrospective Pilot StudyDuska Separovic, Anthony F Shields, Philip A Philip, et al.
The Oncologist|July 13, 2016
Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET RegistryRathan M Subramaniam, Anthony F Shields, Archana Sachedina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 14, 2014
Impact of (18)F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Investigational New Drugs|November 6, 2004
Phase I study of liposomal doxorubicin (Doxil) and cyclophosphamide in solid tumorsBasil F El-Rayes, Dina Ibrahim, Anthony F Shields, et al.
Molecular Imaging and Biology|November 17, 2010
Impact of dedicated brain PET on intended patient management in participants of the national oncologic PET RegistryBruce E Hillner, Barry A Siegel, Anthony F Shields, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 9, 2004
Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancerHaihao Sun, Andrew Sloan, Thomas J Mangner, et al.
Pageof 19